证券研究报告 晨会 hyzqdatemark 2025 年 06 月 24 日 投资要点： 资料来源：聚源，华源证券研究所，截至2025年06月24日 华源晨会精粹 20250624 固定收益 "数据中心 REIT"有何不同？——REITs 系列专题报告：截至 2025 年 6 月 16 日，C-REITs 已累计上市 66 只，累计市值突破 2000 亿元。一级发行方面， 2024 年全年发行上市 29 只 C-REITs，累计发行规模 656 亿元；二级表现上，2025 年 6 月 16 日中证 REITs 全收益指数收于 1117.87 点，较 2025 年初累计涨幅达 14.69%，收益率在各项大类资产中领跑。2025 年 6 月 18 日，"南方万国数据中心 REIT"、"南方润泽科技数据中心 REIT"获批，分别为上交所、深交所的首单数据 中心公募 REITs，底层资产类型进一步扩容。数据中心 REITs 作为新型基础设施资 产，与传统产权类 REITs 在运营模式、收益稳定性、估值逻辑等方面存在显著差异。 C-REITs 二级持仓以券商自营、保险资金为主。"数据中心 REIT"作为"新基建" 的 ...

证券研究报告 | 北交所定期报告 | | --- | hyzqdatemark 2025 年 06 月 23 日 证券分析师 赵昊 SAC：S1350524110004 zhaohao@huayuanstock.com 王宇璇 SAC：S1350525050003 wangyuxuan@huayuanstock.com 下游日化行业发展促进香精香料行业稳步增长，关注北交所相关标的 ——北交所消费服务产业跟踪第十九期（20250620） 投资要点： 请务必仔细阅读正文之后的评级说明和重要声明 联系人 香精香料市场前景向好，下游化妆品行业繁荣拉动需求。2023 年中国香料香精行业 市场规模约为 439 亿元，同比增长 2.6%，预计 2026 年有望突破 500 亿元。随着中 国居民生活水平的提高与消费结构的升级，日化、食品等行业在下游需求的推动下 得到了持续发展，也为香料香精产业链的上游和中游企业提供了广阔的市场空间和 机遇。2023 年中国化妆品市场规模约为 5169.0 亿元，同比增长 6.4%，2025 年有 望增至 5791.0 亿元。化妆品生产通常可分为自主生产和代工生产两种模式，人群、 渠道、品牌多 ...

Core Viewpoint - The company reported a mixed financial performance for 2024, with revenue growth but a significant decline in net profit, indicating challenges in maintaining profitability amidst competitive pressures in the market [1][2]. Financial Performance - In 2024, the company achieved a revenue of 797 million yuan, a year-on-year increase of 26.42%, while the net profit attributable to shareholders was 56 million yuan, down 30.51% year-on-year [1]. - The company's gross profit margin for 2024 was 25.52%, a decrease of 6.65 percentage points compared to the previous year [2]. - The net profit margin for 2024 was 6.90%, down 5.71 percentage points year-on-year, reflecting increased competition and reduced profit margins [2]. Cash Flow and Financial Health - The net cash flow from operating activities in 2024 was 31 million yuan, a decrease of 58.75% year-on-year, primarily due to rising product costs and increased procurement expenses [3]. - The net cash flow from investing activities was -284 million yuan, a decline of 433.73% year-on-year, attributed to the disposal of financial assets and investment returns [3]. - The net cash flow from financing activities increased to 133 million yuan, up 700.33% year-on-year, mainly due to increased bank borrowings [3]. Market Position and Product Offering - The company is a leading producer of mid-to-high-end flavoring agents in China, with a diverse product range including over 310 types of flavors, meeting various downstream application needs [4]. - The company has established stable relationships with major international flavor companies, ensuring a solid customer base and revenue growth [5]. - The global flavor and fragrance market is projected to grow, with the market size expected to reach approximately 32.1 billion USD by 2025, indicating a favorable environment for the company's growth [5][6]. Strategic Initiatives - The company is expanding its overseas market presence to mitigate geopolitical risks, with a new synthetic vanillin production line planned in Thailand [7]. - The Thai production facility has commenced full operations, contributing to performance growth, while domestic capacity expansion is underway [7]. - The company is adapting to new tariffs on imports, implementing a production adjustment plan to maintain competitiveness [7]. Future Outlook - The company is expected to achieve revenues of 1.406 billion yuan, 1.762 billion yuan, and 2.007 billion yuan for 2025-2027, with corresponding net profits of 223 million yuan, 294 million yuan, and 352 million yuan [8]. - The company is well-positioned to benefit from the expanding flavor and fragrance market and its new production capacities, leading to improved economic efficiency [8].

Group 1: Financial Performance - The company's net profit for 2024 is expected to decline due to four main factors: increased fixed asset depreciation, a 37% year-on-year increase in sales team size leading to higher sales expenses, increased R&D investment, and a structural decline in gross margin of core products due to intensified market competition [2][3] - In Q1 2025, the company reported a net profit growth of approximately 360%, attributed to investment income of about 40 million yuan and the efficient operation of the Thai production base [3] Group 2: Operational Insights - The Thai factory achieved approximately 90 million yuan in revenue and 19 million yuan in net profit in Q1 2025, primarily producing vanillin and cooling agents [3] - Long-term contracts account for about 80% of the company's total revenue, with pricing strategies adjusted based on market supply and demand dynamics [3][4] Group 3: Expansion and Product Development - The first phase of the Thai base is fully operational, with the second phase expected to be completed around August 2025, and the third phase in preliminary planning [3] - The company is actively exploring new product developments, such as ambroxan, to meet diverse market and consumer demands [4] - Strategic investment in ABT shares aims to strengthen sales channels and enhance market competitiveness [4]

证券代码：920016 证券简称：中草香料 公告编号：2025-049 安徽中草香料股份有限公司 关于投资者关系活动记录表的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 一、 投资者关系活动类别 √特定对象调研 √业绩说明会 □媒体采访 活动地点：（一）全景网"投资者互动平台"（https://ir.p5w.net）以网络方式 召开业绩说明会。（二）线上会议。 参会单位及人员：（一）业绩说明会：通过网络方式参加 2024 年年度报告暨 2025 年第一季度报告业绩说明会的投资者。（二）线上会议：中泰研究、犁得尔 基金、非马投资、太平基金、观富资产、源乘基金、蜂巢基金、凯丰投资、紫阁 投资（以上排名不分先后）。 上市公司接待人员：（一）业绩说明会：公司董事长、总经理：李莉女士； 财务总监：赵慧女士；董事、董事会秘书：赵娅女士；保荐代表人：邵鸿波先生、 □现场参观 □新闻发布会 □分析师会议 □路演活动 □其他 二、 投资者关系活动情况 活动时间：2025 年 4 月 30 日 王三标先生。（二）线 ...

证券代码：920016 证券简称：中草香料 公告编号：2025-048 安徽中草香料股份有限公司 三、 投资者关系活动主要内容 在本次投资者关系活动中公司向各位投资者简要介绍了公司的基本情况、 主营业务、产品特性等内容。本次投资者关系活动的主要问题及问题回复概要 如下： □业绩说明会 □媒体采访 √现场参观 □新闻发布会 □分析师会议 □路演活动 □其他 1、公司 2024 年度产品收入构成 关于投资者关系活动记录表的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 一、 投资者关系活动类别 √特定对象调研 二、 投资者关系活动情况 活动时间：2025 年 4 月 26 日 活动地点：安徽中草新材料有限公司会议室、厂区 参会单位及人员：洪顺资本、申万宏源研究、东北证券（以上排名不分先后） 上市公司接待人员：董事、董事会秘书赵娅女士 回答：公司产品可以分为凉味剂系列、合成香料系列、天然香料系列，可 以应用于食品、饮料、日化、医药、烟草、饲料等领域，公司产品基本流向产 业链下游企业。 5、预计何时释放新 ...

1 | -1-10 | 言 | | --- | --- | | 黑体加粗 | 回询函所列问题 | | 宋体 | 对问询函所列问题的回复 | | 楷体加粗 | 涉及对招股说明书修改的内容 | 2 3 | 序 | 客户/供应商 | 客户 | 交易 | | | 交易金额(万元) | | | --- | --- | --- | --- | --- | --- | --- | --- | | 号 | 名称" | 类型 | 类型 | 具体内容 | 2022年度 | 2021 年度 | 2020 年度 | | 1 | 上海口隆香料 | 贸易商 | 销售 | 凉味剂 WS-3、 WS-12、代加 | 581.73 | 895.12 | 1.898.57 | | | 有限公司 | | | 工收入等 | | | | | | | | 采购 | 薄荷脑等 | 43.08 | 368.66 | 1,258.52 | | 2 | 上海龙师香精 香料有限公司 | | 销售 | 原味剂 WS-3, | 74.27 | 124.88 | 59.25 | | | | 贸易商 | | WS-23 等 | | | | | | | | 采购 | 2. ...